Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 33.16% is 23% above its 5-year average of 26.98%, near the high end of its 5-year range (11.29%–37.24%).
0.38% below its 12-month average of 33.29%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 33.11%.
EBITDA MARGIN
33.16%
EBITDA MARGIN AVG TTM
33.29%
EBITDA MARGIN AVG 3Y
32.57%
EBITDA MARGIN AVG 5Y
26.98%
EBITDA MARGIN AVG 10Y
28.22%
EBITDA MARGIN AVG 15Y
29.62%
EBITDA MARGIN AVG 20Y
32.02%
CURRENT VS TTM AVG
-0.38%
CURRENT VS 3Y AVG
+1.81%
CURRENT VS 5Y AVG
+22.93%
CURRENT VS 10Y AVG
+17.49%
CURRENT VS 15Y AVG
+11.96%
CURRENT VS 20Y AVG
+3.55%
Market Cap
$240.97B
EBITDA Margin
24.44%
TTM Avg
24.78%
3Y Avg
25.35%
5Y Avg
27.67%
Market Cap
$183.36B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
Market Cap
$177.12B
EBITDA Margin
24.35%
TTM Avg
24.15%
3Y Avg
24.77%
5Y Avg
25.59%
Market Cap
$340.79B
EBITDA Margin
5.21%
TTM Avg
7.15%
3Y Avg
8.47%
5Y Avg
8.86%
Market Cap
$351.56B
EBITDA Margin
34.51%
TTM Avg
30.75%
3Y Avg
31.14%
5Y Avg
33.13%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $252.62B | 33.16% | 33.29% | 32.57% | 26.98% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $240.97B | 24.44% | 24.78% | 25.35% | 27.67% |
| Amgen Inc. (AMGN)vs › | $203.12B | 43.12% | 40.78% | 43.34% | 44.32% |
| Novo Nordisk A/S (NVO)vs › | $185.26B | 48.42% | 49.59% | 48.46% | 47.82% |
| Gilead Sciences, Inc. (GILD)vs › | $183.36B | 49.12% | 32.26% | 34.27% | 33.90% |
| Abbott Laboratories (ABT)vs › | $177.12B | 24.35% | 24.15% | 24.77% | 25.59% |
| UnitedHealth Group Incorporated (UNH)vs › | $340.79B | 5.21% | 7.15% | 8.47% | 8.86% |
| Pfizer Inc. (PFE)vs › | $156.51B | 32.51% | 34.72% | 32.84% | 32.73% |
| Roche Holding AG (RHHBY)vs › | $351.56B | 34.51% | 30.75% | 31.14% | 33.13% |
| Merck & Co., Inc. (MRK)vs › | $358.00B | 45.17% | 41.84% | 33.12% | 31.32% |
Gross Margin
81.9%
EBITDA Margin
33.2%
Operating Margin
22.8%
Net Margin
17.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 33.11% |
| 2026-03-31 | 36.71% |
| 2025-12-31 | 28.96% |
| 2025-09-30 | 33.78% |
| 2025-06-30 | 33.87% |
| 2025-03-30 | 36.49% |
| 2024-12-31 | 18.47% |
| 2024-09-30 | 28.92% |
| 2024-06-30 | 31.11% |
| 2024-03-31 | 34.47% |
| 2023-12-31 | 21.30% |
| 2023-09-30 | 28.16% |
| 2023-06-30 | 32.69% |
| 2023-03-31 | 37.24% |
| 2022-12-31 | 20.95% |
| 2022-09-30 | 23.48% |
| 2022-06-30 | 17.60% |
| 2022-03-31 | 19.20% |
| 2021-12-31 | 15.82% |
| 2021-09-30 | 11.29% |
| 2021-06-30 | 22.87% |
| 2021-03-31 | 36.78% |
| 2020-12-31 | 30.82% |
| 2020-09-30 | 29.98% |
| 2020-06-30 | 31.78% |
| 2020-03-31 | 32.44% |
| 2019-12-31 | 33.31% |
| 2019-09-30 | 22.99% |
| 2019-06-30 | 20.95% |
| 2019-03-31 | 32.29% |
| 2018-12-31 | 42.68% |
| 2018-09-30 | 29.01% |
| 2018-06-30 | 28.07% |
| 2018-03-31 | 27.13% |
| 2017-12-31 | 31.04% |
| 2017-09-30 | 28.95% |
| 2017-06-30 | 30.51% |
| 2017-03-31 | 29.14% |
| 2016-12-31 | 55.92% |
| 2016-09-30 | 28.76% |
| 2016-06-30 | 15.88% |
| 2016-03-31 | 26.28% |
| 2015-12-31 | 28.19% |
| 2015-09-30 | 29.29% |
| 2015-06-30 | 25.99% |
| 2015-03-31 | 29.42% |
| 2014-12-31 | 10.06% |
| 2014-09-30 | 21.06% |
| 2014-06-30 | 26.72% |
| 2014-03-31 | 23.96% |
| 2013-12-31 | 29.43% |
| 2013-09-30 | 33.50% |
| 2013-06-30 | 34.32% |
| 2013-03-31 | 32.08% |
| 2012-12-31 | 37.46% |
| 2012-09-30 | 43.42% |
| 2012-06-30 | 35.71% |
| 2012-03-31 | 36.18% |
| 2011-12-31 | 36.24% |
| 2011-09-30 | 58.50% |
| 2011-06-30 | 41.23% |
| 2011-03-31 | 47.36% |
| 2010-12-31 | 43.15% |
| 2010-09-30 | 38.09% |
| 2010-06-30 | 42.37% |
| 2010-03-31 | 47.15% |
| 2009-12-31 | 34.66% |
| 2009-09-30 | 44.72% |
| 2009-06-30 | 41.66% |
| 2009-03-31 | 46.07% |
| 2008-12-31 | 34.41% |
| 2008-09-30 | 39.25% |
| 2008-06-30 | 36.88% |
| 2008-03-31 | 38.54% |
| 2007-12-31 | 30.37% |
| 2007-09-30 | 36.18% |
| 2007-06-30 | 32.20% |
| 2007-03-31 | 36.46% |
| 2006-12-31 | 33.98% |
| 2006-09-30 | 37.37% |
| 2006-06-30 | 36.78% |
| 2006-03-31 | 36.54% |
| 2005-12-31 | 32.29% |
| 2005-09-30 | 34.51% |
| 2005-06-30 | 33.25% |
| 2005-03-31 | 30.68% |
| 2004-12-31 | -44.65% |
| 2004-09-30 | 27.79% |
| 2004-06-30 | 25.62% |
| 2004-03-31 | 26.69% |
| 2003-12-31 | 25.42% |
| 2003-09-30 | 33.01% |
| 2003-06-30 | 23.32% |
| 2003-03-31 | 32.61% |
| 2002-12-31 | 21.05% |
| 2002-09-30 | 26.63% |
